Financials SANA AB

Equities

SANION

SE0005794617

Biotechnology & Medical Research

Market Closed - Nasdaq Stockholm 11:29:55 2024-06-04 am EDT 5-day change 1st Jan Change
2.475 SEK -1.20% Intraday chart for SANA AB +22.52% -38.28%

Valuation

Fiscal Period: December 2019 2021 2022 2023 2024 2025
Capitalization 1 730.2 552.1 191.2 257.1 275.3 -
Enterprise Value (EV) 1 691.4 552.1 191.2 257.1 271.1 275.3
P/E ratio - -1.34 x -0.78 x - - -
Yield - - - - - -
Capitalization / Revenue 270 x - 12.5 x 15.3 x 4.44 x 4.92 x
EV / Revenue 256 x - 12.5 x 15.3 x 4.37 x 4.92 x
EV / EBITDA -6.8 x - -0.88 x -3.6 x -10 x -8.6 x
EV / FCF -6.78 x - -0.68 x -3 x -7.75 x -14.5 x
FCF Yield -14.7% - -148% -33.3% -12.9% -6.9%
Price to Book 12.2 x - - - - -
Nbr of stocks (in thousands) 28,413 62,386 62,386 64,127 111,238 -
Reference price 2 25.70 8.850 3.065 4.010 2.475 2.475
Announcement Date 2/7/20 2/24/22 2/23/23 2/29/24 - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2021 2022 2023 2024 2025
Net sales 1 2.7 - 15.28 16.84 62 56
EBITDA 1 -101.7 - -217.9 -71.41 -27 -32
EBIT 1 -103.9 - -225.7 -81.06 -29 -38
Operating Margin -3,848.15% - -1,476.93% -481.38% -46.77% -67.86%
Earnings before Tax (EBT) 1 -83.5 - -252 -104.3 -37 -43
Net income 1 -75.8 -410.9 -245.4 -95.81 -37 -43
Net margin -2,807.41% - -1,605.42% -568.94% -59.68% -76.79%
EPS - -6.590 -3.930 - - -
Free Cash Flow 1 -102 - -282.5 -85.66 -35 -19
FCF margin -3,776.19% - -1,848.6% -508.67% -56.45% -33.93%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 2/7/20 2/24/22 2/23/23 2/29/24 - -
1SEK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2021 2022 2023 2024 2025
Net Debt 1 - - - - - -
Net Cash position 1 38.8 - - - 4.2 -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -102 - -283 -85.7 -35 -19
ROE (net income / shareholders' equity) - - - - - -
ROA (Net income/ Total Assets) -84.6% - - - - -
Assets 1 89.55 - - - - -
Book Value Per Share 2.100 - - - - -
Cash Flow per Share - - - - - -
Capex 3.49 - - - - -
Capex / Sales 129.19% - - - - -
Announcement Date 2/7/20 2/24/22 2/23/23 2/29/24 - -
1SEK in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise